BioCentury

7:00 AM GMT, Aug 22, 2011
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Regulatory

Pradaxa dabigatran etexilate regulatory update

The U.K.'s NICE asked for additional information on the cost-effectiveness of Pradaxa dabigatran from Boehringer before recommending the

Read the full 182 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.